Ester compound
US-2024025838-A1 · Jan 25, 2024 · US
Treatment of ovarian cancer with benzylidenebenzohydrazides
US9029403B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9029403-B2 |
| Application number | US-201214357429-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 9, 2012 |
| Priority date | Nov 10, 2011 |
| Publication date | May 12, 2015 |
| Grant date | May 12, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Methods for inhibiting the growth of ovarian cancer cells or other serosal cancer cells are disclosed. The method involves exposing the cells to a benzylidinebenzohydrazide of formula: wherein X is carbon or nitrogen.
First claim
Opening claim text (preview).
The invention claimed is: 1. A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound of formula: wherein: R 6a is chosen from H, —N(CH 3 ) 2 , —N(CH 2 CH 3 ) 2 , —OH, —OCH 3 , and —OCH 2 CH 3 ; R 7a and R 8 are hydrogen, or R 7a and R 8 taken together may form an optionally substituted six-membered carbocyclic ring;…
Assignees
Inventors
Classifications
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Chemistry & Metallurgy · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9029403B2 cover?
- Methods for inhibiting the growth of ovarian cancer cells or other serosal cancer cells are disclosed. The method involves exposing the cells to a benzylidinebenzohydrazide of formula: wherein X is carbon or nitrogen.
- Who is the assignee on this patent?
- Sloan Kettering Inst Cancer
- What technology area does this patent fall under?
- Primary CPC classification C07D307/68. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).